MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care.
MediLynx underwent a rigorous review on December 13, 2021, where a Joint Commission reviewer evaluated compliance with Ambulatory Health Care standards spanning several areas including patient safety, quality measures and coordination of care. The Joint Commission’s standards are developed in consultation with health care experts and providers, measurement experts and patients. They are informed by scientific literature and expert consensus to help health care organizations measure, assess and improve performance.
“As a private accreditor, The Joint Commission surveys health care organizations to protect the public by identifying deficiencies in care and working with those organizations to correct them as quickly and sustainably as possible,” says Mark Pelletier, RN, MS, Chief Operating Officer, Accreditation and Certification Operations, and Chief Nursing Executive, The Joint Commission. “We commend MediLynx for its continuous quality improvement efforts in patient safety and quality of care.”
“MediLynx is delighted to receive accreditation from The Joint Commission, world renowned for accrediting organizations which deliver the highest standards for patient quality of care,” says William Moody, Chief Operating Officer at MediLynx. “Providing outstanding patient care is at the heart of who we are and achieving Joint Commission accreditation validates the efforts we take and importance we place on that mission.”